Pelubiprofen: Difference between revisions
CSV import |
CSV import |
||
| Line 10: | Line 10: | ||
==Pharmacology== | ==Pharmacology== | ||
Pelubiprofen works by inhibiting the [[cyclooxygenase]] (COX) enzymes | Pelubiprofen works by inhibiting the [[cyclooxygenase]] (COX) enzymes, which are involved in the synthesis of [[prostaglandins]]. Prostaglandins are mediators of inflammation and pain, and by reducing their production, pelubiprofen alleviates symptoms associated with inflammatory conditions. | ||
== | ===Mechanism of Action=== | ||
Pelubiprofen selectively inhibits the COX-2 enzyme, which is primarily responsible for the synthesis of inflammatory prostaglandins. This selectivity helps in reducing inflammation and pain while minimizing gastrointestinal side effects commonly associated with non-selective COX inhibitors. | |||
== | ==Clinical Uses== | ||
Pelubiprofen is indicated for the management of pain and inflammation in conditions such as: | |||
Pelubiprofen is indicated for the management of pain and inflammation | |||
* [[Rheumatoid arthritis]] | * [[Rheumatoid arthritis]] | ||
* [[Osteoarthritis]] | * [[Osteoarthritis]] | ||
| Line 29: | Line 23: | ||
==Side Effects== | ==Side Effects== | ||
Common side effects of pelubiprofen include: | |||
* [[Gastrointestinal]] | * [[Gastrointestinal discomfort]] | ||
* [[Nausea]] | * [[Nausea]] | ||
* [[Dizziness]] | * [[Dizziness]] | ||
* [[Headache]] | * [[Headache]] | ||
Serious side effects may include | Serious side effects, although rare, may include: | ||
* [[Gastrointestinal bleeding]] | |||
* [[Renal impairment]] | |||
* [[Hepatotoxicity]] | |||
== | ==Synthesis== | ||
Pelubiprofen | [[File:Pelubiprofen_synthesis.svg|Synthesis of Pelubiprofen|thumb|right]] | ||
The synthesis of pelubiprofen involves the condensation of 4-bromobenzoyl chloride with 2-methylpropionic acid, followed by a series of reactions to form the final product. The process is designed to optimize yield and purity, ensuring the production of a pharmacologically active compound. | |||
==Related pages== | ==Related pages== | ||
* [[Nonsteroidal anti-inflammatory drug]] | * [[Nonsteroidal anti-inflammatory drug]] | ||
* [[Cyclooxygenase]] | * [[Cyclooxygenase]] | ||
* [[Prostaglandin]] | |||
[[Category:Nonsteroidal anti-inflammatory drugs]] | [[Category:Nonsteroidal anti-inflammatory drugs]] | ||
[[Category: | [[Category:Analgesics]] | ||
[[Category:Anti-inflammatory agents]] | |||
Latest revision as of 19:14, 6 March 2025
Nonsteroidal anti-inflammatory drug
| Pelubiprofen | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Pelubiprofen is a nonsteroidal anti-inflammatory drug (NSAID) used primarily for its analgesic and anti-inflammatory properties. It is commonly prescribed for the treatment of rheumatoid arthritis, osteoarthritis, and other musculoskeletal disorders.
Pharmacology[edit]
Pelubiprofen works by inhibiting the cyclooxygenase (COX) enzymes, which are involved in the synthesis of prostaglandins. Prostaglandins are mediators of inflammation and pain, and by reducing their production, pelubiprofen alleviates symptoms associated with inflammatory conditions.
Mechanism of Action[edit]
Pelubiprofen selectively inhibits the COX-2 enzyme, which is primarily responsible for the synthesis of inflammatory prostaglandins. This selectivity helps in reducing inflammation and pain while minimizing gastrointestinal side effects commonly associated with non-selective COX inhibitors.
Clinical Uses[edit]
Pelubiprofen is indicated for the management of pain and inflammation in conditions such as:
- Rheumatoid arthritis
- Osteoarthritis
- Ankylosing spondylitis
- Acute musculoskeletal pain
Side Effects[edit]
Common side effects of pelubiprofen include:
Serious side effects, although rare, may include:
Synthesis[edit]

The synthesis of pelubiprofen involves the condensation of 4-bromobenzoyl chloride with 2-methylpropionic acid, followed by a series of reactions to form the final product. The process is designed to optimize yield and purity, ensuring the production of a pharmacologically active compound.